title: Cardiovascular considerations in selection of anti-panic pharmacotherapy.
abstract: Patients with panic disorder may be at increased risk for cardiovascular morbidity and mortality. There is also preliminary evidence that some cardiovascular risk factors may be increased in patients with panic disorder. Since anti-panic medications can alter cardiovascular function, the cardiovascular effect of these medications should be considered, particularly when used in patients with cardiovascular disease. This article will review the cardiovascular side effects of anti-panic medications.
authors.affiliation: Department of Psychiatry, Stanford Medical School, CA 94305-5490.
authors.forename: C B
authors.initials: CB
authors.lastname: Taylor
authors.forename: C
authors.initials: C
authors.lastname: Hayward
mesh_terms: D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D001143:Arousal / Q000187:drug effects*; D001569:Benzodiazepines; D004562:Electrocardiography / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D010200:Panic / Q000187:drug effects*; D012307:Risk Factors
chemical_list: D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D001569:Benzodiazepines